메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한뇌졸중학회 대한뇌졸중학회지 대한뇌졸중학회지 제12권 제3호
발행연도
2010.1
수록면
102 - 105 (4page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Although the number of the elderly stroke patients increases, treatment with intravenous recombinant tissue plasminogen activator (rt-PA) is currently not recommended in the elderly. We investigated the safety and clinical outcome of the intravenous thrombolysis in the elderly. Methods: We consecutively enrolled patients who underwent intravenous rt-PA thrombolysis according to the treatment protocol based on the American heart association guidelines. The demographic data, initial national institutes of health stroke scale score and stroke subtype were assessed. The clinical outcomes were modified Rankin Scale (mRS) at 3 months. Symptomatic intracranial hemorrhage causing any neurological decline was evaluated. All clinical data were compared between patients who were 80 years or older and those less than 80 years. Results: Of the total 46 patients, 7 (15.2%) patients were 80 years or older. The baseline characteristics were comparable between both groups. Symptomatic hemorrhagic transformation was not different between both groups [0/7 (0%) vs. 3/39 (7.7%), P>0.999]. There was no difference in favorable outcome (mRS 0-2) and mortality between both groups [2/7 (28.6%) vs. 25/37 (67.6%), P=0.089, 1/7 (14.3%) vs. 4/37 (10.8%), P>0.999, respectively]. Conclusion: Symptomatic intracranial hemorrhage was not higher in the elderly and the favorable clinical outcome was comparable between the two groups. (Korean J Stroke 2010;12:102-105)

목차

등록된 정보가 없습니다.

참고문헌 (14)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0